syphilis
The firm plans to file for regulatory approval of its first test, a chemiluminescent ELISA for respiratory disease, as early as the first quarter of 2024.
Chembio Diagnostics Gets CLIA Waiver for HIV-Syphilis Dual Rapid Test
The test can detect both HIV and syphilis from a single sample in 15 minutes using fingerstick blood, venous whole blood, or plasma.
MedMira, Maternova Sign Distribution Deal for Infectious Disease Tests in US, Latin America
The point-of-care immunoassays covered under the deal include ones for HIV, syphilis, hepatitis, and SARS-CoV-2.
Biosynex to Acquire Chembio Diagnostics for $17.2M
Biosynex will buy all of Chembio's shares at $.45 per share in an all-cash deal that merges two developers and makers of point-of-care diagnostic tests.
Chembio Diagnostics Receives $3.2M From CDC to Develop Syphilis Test
The rapid assay is intended to simultaneously and separately detect treponemal and nontreponemal IgM and IgG antibodies.
Jul 26, 2022
Mar 12, 2021
Aug 16, 2018
STD Testing Firm MyLab Box Raises $1.56M
May 9, 2018
Chembio Q1 Revenues Rise 22 Percent
Mar 8, 2018
Chembio Q4 Revenues Grow 40 Percent
Jun 12, 2017
Bio-Rad Gets FDA Clearance for Syphilis Assay
May 10, 2017
Chembio Diagnostics' Q1 Revenues Drop 5 Percent
Mar 8, 2017